We are proud of the groundbreaking solutions we’ve been developing for COVID-19 and glioma tumors. Our development pipeline illustrates the progress we’re making and our plans for the future.

  • Two pending provisional patents approaching final submission phase
  • Conducted clinical trials for treatment of other diseases in pilot labs
  • The cornerstone was laid for building beginning on 14.5.2020 for 4,200 sq meter production facility in Israel